The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...

A digital toolkit with patient scripts, risk calculator comparisons and more could help primary care and OB/GYN providers ...

A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting ...

Three bright blue dogs spotted outside the Chernobyl nuclear plant in October 2024 triggered a global wave of speculation that quickly outpaced the facts. Photos of the animals, roaming near the edge ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.

A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch ...

Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

Broadcast Retirement Network's Jeffrey Snyder discusses improving autism evaluation and diagnosis with Dr. Bahar Tungenc of ...